SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-------------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Earliest Event Reported: January 15, 2001
GreatBio Technologies, Inc.
--------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Nevada 0-26057 82-0507874
---------------------------------------------------------------------------
(State or other jurisdiction of (Commission File Number) (IRS Employer
incorporation or organization) Identification No.)
Tech Enterprise Center Suite 201,
150 Lucius Gordon Drive,
West Henrietta, NY 14586
----------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (716) 214-2441
<PAGE>
ITEM 4. CHANGE IN REGISTRANT'S CERTIFIYING ACCOUNTANTS
(a) Previous independent accountants
On January 16, 2001, GreatBio Technologies, Inc. dismissed
LeMaster & Daniels PLLC as its independent accountants. The
Registrant's Board of Directors approved the decision to
change independent accountants. The reports of LeMaster &
Daniels PLLC on the financial statements for the past two
fiscal years contained no adverse opinion or disclaimer of
opinion, audit scope or accounting principle. However,
LeMaster & Daniels did report uncertainty as to the company's
ability to continue as a going concern. In connection with
its audits for the two most recent fiscal years and through
January 15, 2001 there have been no disagreements with
LeMaster & Daniels PLLC on any matter of accounting
principles or practices, financial statement disclosure, or
auditing scope or procedure, which disagreements if not
resolved to the satisfaction of LeMaster & Daniels PLLC would
have caused them to make reference thereto in their report
on the financial statements for such years. During the two
most recent fiscal years and through January 15, 2001, there
have been no reportable events as defined in Regulation S-K
Item 304(a)(1)(v). The Registrant has requested that
LeMaster & Daniels PLLC furnish it with a letter addressed to
the SEC stating whether or not it agrees with the above
statements. A copy of such letter, dated January __ 2001, is
filed as Exhibit 16 to this Form 8-K.
(b) New independent accountants
The Registrant engaged Arthur Andersen LLP as its new
independent accountants as of January 15, 2001. During the
two most recent fiscal years and through January 15, 2001,
the Registrant has not consulted with Arthur Andersen LLP
regarding either (i) the application of accounting principles
to a specified transaction, either completed or proposed; or
the type of audit opinion that might be rendered on the
Registrant's financial statements, and neither a written
report nor oral advice was provided to the Registrant that
was an important factor considered by the Registrant in
reaching a decision as to the accounting, auditing or
financial reporting issue; or (ii) any matter that was
either the subject of a disagreement, as that term is defined
in Item 304(a)(1)(iv) of Regulation S-K and the related
instructions to Item 304 of Regulation S-K, or a reportable
event, as that term is defined in Item 304(a)(1)(v) of
Regulation S-K.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(c) Exhibits.
Page
(16) Letter regarding change in certifying accountant. 3
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
Dated: January 17, 2001
GreatBio Technologies, Inc.
By: /s/ Michael L. Weiner
----------------------------
Name: Michael L. Weiner
Title: President